Numerous risk-group stratification, staging and scoring systems exist to stratify patients with differentiated thyroid cancer into prognostic risk groups that guide patient management decisions. The tumor–node–metastasis staging system is the most widely adopted despite its relative complexity, but could a simplified, quantitative alternative to the system provide superior prognostic value?
- Brian H. H. Lang
- Chung-Yau Lo
